We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

180 hedge funds and large institutions have $1.69B invested in Heron Therapeutics in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 73 increasing their positions, 39 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 39

48% more call options, than puts

Call options by funds: $8.62M | Put options by funds: $5.82M

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

2% more funds holding

Funds holding: 176 → 180 (+4)

3% less capital invested

Capital invested by funds: $1.74B → $1.69B (-$52.9M)

3.99% less ownership

Funds ownership: 118.54% → 114.55% (-4%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
180
Holders Change
+4
Holders Change %
+2.27%
% of All Funds
3.95%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
29
Increased
73
Reduced
39
Closed
24
Calls
$8.62M
Puts
$5.82M
Net Calls
+$2.79M
Net Calls Change
+$2.4M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$18.6M
2
ClearBridge Investments
ClearBridge Investments
New York
+$13.6M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.63M
4
Artisan Partners
Artisan Partners
Wisconsin
+$7.3M
5
CS
Candriam SCA
Luxembourg
+$6.22M

Top Sellers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
-$26.7M
2
State Street
State Street
Massachusetts
-$24.8M
3
CTA
Carillon Tower Advisers
Florida
-$23.7M
4
BC
Broadfin Capital
New York
-$10.3M
5
SI
Sofinnova Investments
California
-$9.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECP
26
Elk Creek Partners
Colorado
$11.6M -$784K -42,604 -6%
Millennium Management
27
Millennium Management
New York
$10.5M +$4M +217,302 +62%
PCM
28
Palisade Capital Management
New Jersey
$10M +$615K +33,398 +7%
KCM
29
Kingdon Capital Management
New York
$9.36M -$5.98M -325,092 -39%
Deutsche Bank
30
Deutsche Bank
Germany
$8.92M -$832K -45,187 -9%
Charles Schwab
31
Charles Schwab
California
$7.89M +$163K +8,875 +2%
HA
32
Heartland Advisors
Wisconsin
$7.4M – – –
N
33
Nuveen
North Carolina
$7.16M +$29.3K +1,594 +0.4%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$6.19M +$453K +24,602 +8%
Invesco
35
Invesco
Georgia
$5.34M – – –
PC
36
Pier Capital
Connecticut
$5M +$182K +9,899 +4%
ORI
37
Oak Ridge Investments
Illinois
$4.92M +$2.9M +157,309 +145%
Bank of America
38
Bank of America
North Carolina
$4.89M -$1.95M -105,829 -29%
GLA
39
Great Lakes Advisors
Illinois
$4.78M +$4.75M +258,201 New
UBS Group
40
UBS Group
Switzerland
$4.46M +$1.13M +61,140 +34%
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
$4.16M +$2.04M +110,892 +97%
PAM
42
Panagora Asset Management
Massachusetts
$3.62M -$8.36M -454,176 -70%
Susquehanna International Group
43
Susquehanna International Group
Pennsylvania
$3.45M +$805K +43,745 +31%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$3.09M +$41.6K +2,258 +1%
American Century Companies
45
American Century Companies
Missouri
$3.04M +$186K +10,118 +7%
Citigroup
46
Citigroup
New York
$2.72M -$1.41M -76,788 -34%
CCM
47
Cohen Capital Management
California
$2.63M – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$2.61M +$55.2K +3,000 +2%
RSS
49
Rosenblum Silverman Sutton
California
$2.59M -$8.72K -474 -0.3%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$2.58M +$1.47M +79,900 +134%
1
2
3 4 5

HRTX Hedge Fund Activity: Q3 2019 in Review

180 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2019, worth a combined $1.69B — down 3% from $1.74B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new HRTX positions and 24 closed out — a net gain of 5 holders — while 73 added to existing stakes and 39 trimmed.

The largest buyer was Franklin Resources, adding an estimated $18.6M. The largest seller was Eagle Asset Management, exiting entirely with an estimated $26.7M sold.

  • 180 institutional investors held Heron Therapeutics (HRTX) as of Q3 2019, up from 176 in Q2 2019.
  • Funds reported $1.69B of Heron Therapeutics stock for Q3 2019, down 3% quarter-over-quarter.
  • 29 funds opened new Heron Therapeutics positions in Q3 2019 and 24 closed out, a net change of +5 holders.
  • The largest Heron Therapeutics buyer in Q3 2019 was Franklin Resources, an estimated $18.6M added.
  • The largest Heron Therapeutics seller in Q3 2019 was Eagle Asset Management, an estimated $26.7M sold.

Based on aggregated 13F filings for Q3 2019.